# Study of Levalbuterol, Racemic Albuterol and Placebo in Subjects Twelve Years of Age and Older With Asthma

> **NCT00073827** · PHASE3 · COMPLETED · sponsor: **Sumitomo Pharma America, Inc.** · enrollment: 445 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** levalbuterol tartrate MDI
- **DRUG:** racemic albuterol MDI
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00073827
- **Lead sponsor:** Sumitomo Pharma America, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-05
- **Primary completion:** 2003-01
- **Final completion:** 2003-01
- **Target enrollment:** 445 (ACTUAL)
- **Last updated:** 2012-02-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00073827

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00073827, "Study of Levalbuterol, Racemic Albuterol and Placebo in Subjects Twelve Years of Age and Older With Asthma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00073827. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*